Loan Loss Reserves / Non-Performing Loans (Quarterly)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

TriSalus Life Sciences, Inc. (TLSI) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$11.57M
Net Income	$-41.27M
Cost of Goods Sold	$1.91M
Gross Profit	$9.66M
Operating Expenses	$20.58M
Operating Income	$-9.01M
Non-Operating Income/Expense	$-1.79M
Pre-Tax Income	$-10.81M
Normalized Pre-Tax Income	$-10.81M
Income after Taxes	$-10.80M
Income from Continuous Operations	$-10.80M
Consolidated Net Income/Loss	$-10.81M
Normalized Income after Taxes	$-10.80M
EBIT	$-9.01M
EBITDA	$-8.58M
Weighted-Average Shares Outstanding (Basic)	43.06M
Weighted-Average Shares Outstanding (Diluted)	43.06M
Earnings per Share (EPS) (Basic)	$-0.96
Earnings per Share (EPS) (Diluted)	$-0.96
Balance Sheet Financials
Current Assets	$33.33M
Property, Plant, and Equipment	$1.83M
Long-Term Assets	$3.13M
Total Assets	$36.46M
Current Liabilities	$10.91M
Long-Term Debt	$32.76M
Long-Term Liabilities	$52.28M
Total Liabilities	$63.19M
Common Equity	$-26.73M
Tangible Shareholders Equity	$-26.73M
Shareholders Equity	$-26.73M
Common Shares Outstanding	49.89M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-15.53M
Cash Flow from Investing Activities	$-0.80M
Cash Flow from Financial Activities	$30.49M
Beginning Cash	$8.88M
End Cash	$23.04M
Increase/Decrease in Cash	$14.16M
Stock-Based Compensation	$6.93M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.05
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	5.43
Debt to Equity Ratio	-1.23
Gross Margin	83.52%
Operating Margin	-77.94%
EBIT Margin	-77.94%
EBITDA Margin	--
Pre-Tax Profit Margin	-93.43%
Profit Margin	-356.86%
Free Cash Flow	$-16.32M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.32
Inventory Turnover	0.58
Receiveable Turnover	2.31
Days Sales in Receivables	38.91
Return on Equity	40.42%
Return on Tangible Equity	40.42%
Return on Assets	-29.62%
Return on Investments	-178.85%
Book Value Per Share	$-0.54
Free Cash Flow per Share	$-0.38
Operating Cash Flow per Share	$-0.36

Data from Zacks Investment Research, Inc.